Nippon India Pharma Fund vs DSP Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8737 Cr | ₹3190 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 05 Jun 2004 | 30 Nov 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 18% |
Expense Ratio | 1.82 | 1.9 |
Manager | Sailesh Raj Bhan | Jay Kothari |
ISIN Code | INF204K01968 | INF740KA1LD8 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Month | 0.14% | -0.4% |
6 Month | 11.82% | 6.31% |
1 Year | 5.07% | 6.37% |
3 Year | 23.02% | 24.21% |
5 Year | 18.61% | 19.51% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
6 Month | 4.46% | 5.01% |
1 Year | 7.63% | 3.32% |
3 Year | 22.46% | 22.35% |
5 Year | 18.88% | 19.16% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Year | 17.31% | 26.14% |
3 Year | 20.52% | 20.91% |
5 Year | 20.64% | 26.64% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Standard Deviation | 14.61% | 14.38% |
Sharp | 1.14% | 1.18% |
Beta | 0.90% | 0.84% |
Alpha | 0.72% | 2.18% |
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Name | Sailesh Raj Bhan | Jay Kothari |
Total AUM | ₹96086 Cr | ₹0 Cr |
Funds Managed | 5 | 20 |
Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 1.47 | 14.85 |
Large Cap | 34.68 | 16.94 |
Mid Cap | 32.06 | 14.46 |
Small Cap | 31.79 | 53.75 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 0.55 | 2.42 |
Healthcare | 99.45 | 96.12 |
Financial Services | - | 1.46 |
Top Comparisons
ITI Banking and PSU Fund Regular - Growth
3Y Returns6.98%
Kotak Banking and PSU Debt - Growth
3Y Returns7.47%
Motilal Oswal Balance Advantage Fund (MOFDYNAMIC) - Regular Plan - Growth Option
3Y Returns8.6%
360 ONE Balanced Hybrid Fund Regular - Growth
3Y Returns0%
WhiteOak Capital Special Opportunities Fund-Reg (G)
3Y Returns0%
NIPPON INDIA ANNUAL INTERVAL FUND SERIES I GROWTH PLAN
3Y Returns6.68%
ICICI Prudential Credit Risk Fund - Growth
3Y Returns7.94%
HSBC Credit Risk Fund - Regular Growth
3Y Returns11.1%